Cyteir Therapeutics, Inc.
CYTDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001662244
Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.
Holders of 5% or more of CYT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cyteir Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Cyteir Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Cyteir Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 3, 2023 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Jul 26, 2023 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Jul 10, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Baker Bros. Advisors LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Avidity Partners Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2023 | Osage University GP II, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 26, 2023 | BML Investment Partners, L.P. | 13GOld format | – | New | – | SEC |
| Sep 30, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Aug 15, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Jul 25, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Venrock Associates VII, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Lightstone Ventures II, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Avidity Partners Management LP | 13GOld format | – | New | – | SEC |
| Feb 11, 2022 | Janus Henderson Group PLC | 13GOld format | – | New | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2022 | Osage University GP II, LLC | 13GOld format | – | New | – | SEC |
| Dec 20, 2021 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Oct 12, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
| Jun 29, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Jun 25, 2021 | Novo Holdings A/S | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Cyteir Therapeutics, Inc. shares.
No Form 144 notices for Cyteir Therapeutics, Inc. are on file.